recorded webinar

Medications for Anxiety Disorders and PTSD: Current Trends and Future Directions

Off

Featuring:

Sanjay Mathew, MD - ADAA Chief Medical Officer and Board Secretary
and
Consumer
Professional
Medications for Anxiety Disorders and PTSD
Thursday, May 05, 2022 12:00 pm
- 1:00 pm ET
CE/CME Credit
0.00

 

This webinar describes current medication therapies for anxiety disorders and PTSD, focusing on FDA-approved and evidence-based approaches. Experimental drugs in development is reviewed, as well as the neurobiological rationale for their use.  The risk/benefit profile and limitations of pharmacotherapies is discussed.

Learning Objectives

  1. To understand current trends in medication prescribing for the most common anxiety disorders and PTSD.
  2. To describe novel mechanisms of action of several medications in development for these conditions.
  3. To describe the recent FDA statement on the prescribing of benzodiazepines.
Presenter(s) Biography

Sanjay Mathew, MD - ADAA Chief Medical Officer and Board Secretary

Sanjay J. Mathew, M.D. is the Marjorie Bintliff Johnson and Raleigh White Johnson, Jr. Vice Chair for Research and Professor in the Menninger Department of Psychiatry & Behavioral Sciences at Baylor College of Medicine. He is also a staff psychiatrist at the Michael E. Debakey VA Medical Center (MEDVAMC) in Houston, Texas. He graduated from Dartmouth College and Baylor College of Medicine, and trained in psychiatry at Columbia University and the New York State Psychiatric Institute, where he also completed a NIH-funded research fellowship in affective and anxiety disorders. Dr. Mathew began his faculty career at the Icahn School of Medicine at Mount Sinai where he co-founded and directed the Mood & Anxiety Disorders Program. In 2010, Dr. Mathew was recruited back to his hometown of Houston to direct Baylor’s Mood & Anxiety Disorders Program. His research program focuses on developing novel therapies for patients with treatment-resistant mood and anxiety disorders and PTSD, with a particular focus on rapid-acting glutamate-modulating agents. 

Dr. Mathew’s research program has been funded by NIMH, Department of Veterans Affairs, Patient-Centered Outcomes Research Institute (PCORI), and industry in the areas of experimental therapeutics and pathophysiology of treatment-resistant depression, suicide, and PTSD. He has authored or co-authored over 130 manuscripts and book chapters, and serves on the editorial board of several journals. In addition to his long involvement with ADAA including serving as Chair of the Program Committee (2017-2018), Dr. Mathew is a member of the American College of Neuropsychopharmacology, and board member of the American Society of Clinical Psychopharmacology. Dr. Mathew is ADAA Chief Medical Officer and Board Secretary. An active clinician and teacher, Dr. Mathew has been selected by his peers as a “Best Doctor” every year since 2011, and has received awards for his teaching of psychopharmacology.

and
Professional Post
Off
CE/CME Accreditation Statement
RESOURCES AND NEWS
Evidence-based Tips & Strategies from our Member Experts
RELATED ARTICLES
Block reference
TAKING ACTION

With the #MeToo movement and the rising numbers of people affected by mental health, romance…

Advertisement

ADAA Continuing Education Credits for Live and On-Demand Programming

Learners complete an evaluation form to receive a certificate of completion. You must participate in the entire activity as partial credit is not available.  If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.

Some ADAA professional webinars focused on diversity or cultural competency subject matter are eligible for the Cross-Culture Competency Diversity Credit. If a webinar is eligible for this credit, it will be reflected on your credit certificate.

All continuing education credits are provided through Amedco, LLC. Learn more about the CE/CME accreditation information here.